EHC/LinkedIn
Apr 7, 2026, 16:44
A Call to Get the Biotech Act Right for The Millions Living with Bleeding Disorders – EHC
EHC – European Haemophilia Consortium shared on LinkedIn:
”Innovation without access is not progress.
On World Health Day, the EHC is calling on EU policymakers to get the Biotech Act right for the millions living with bleeding disorders who cannot afford to wait.
Science is moving fast.
Regulation and access must keep up.
The EHC demands:
- Patients at the table, not as an afterthought, but at every stage of research, trials, and regulatory decisions
- Real-world evidence that counts, because clinical trial data alone do not capture the full picture of patients’ lives
- Cross-border clinical trials to break down barriers and bring innovation to patients across Europe, no matter where they live
The theme of World Health Day 2026 is ‘Together for health: stand with science’.
Standing with science means ensuring that science stands for patients.
The EU Biotech Act is an opportunity. Let’s not waste it.
Stay updated with Hemostasis Today.
-
Aug 26, 2026, 18:38Maia Meier: Muhiba’s Story of Courage, Resilience and Hope With Type 3 VWD
-
Aug 26, 2026, 18:27Isabella Presch: Not Every Genome-Editing Program Needs to Start From Zero
-
Aug 26, 2026, 18:24New Educational Content for the Bleeding Disorders Community – EAHAD
-
Aug 26, 2026, 18:14N. Mariana S. Vasquez: From Skin and Gut to Celiac Disease
-
Aug 26, 2026, 18:13Francesca Granata: What Happens When Patients Become Researchers and Researchers Become Advocates?
-
Aug 26, 2026, 18:11Maxima Mendez: Statins Are No Longer the Whole Story
-
Aug 26, 2026, 18:06Ashkan Shoamanesh: ANNEXa-I Analyses Inform Individualized Treatment in Intracranial Hemorrhage
-
Aug 26, 2026, 18:01Sam Tsimikas: Lp(a) and Oxidized Phospholipids Reveal a New Link Between Hypercoagulability and Stronger Clot Formation
-
Aug 26, 2026, 17:52Kamlesh Darji: A Practical Guide to Interpreting Coagulation Tests